AIA
ABBV icon

AssuredPartners Investment Advisors’s AbbVie ABBV Stock Holding History

AssuredPartners Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.05M Buy
24,452
+16,772
+218% +$3.72M 0.55% 45
2025
Q4 		$1.75M Buy
7,680
+230
+3% +$52.4K 0.26% 96
2025
Q3 		$1.73M Buy
7,450
+226
+3% +$46K 0.38% 50
2025
Q2 		$1.34M Sell
7,224
-452
-6% -$84K 0.33% 58
2025
Q1 		$1.61M Buy
7,676
+914
+14% +$178K 0.31% 92
2024
Q4 		$1.2M Buy
+6,762
New +$1.24M 0.23% 104

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AssuredPartners Investment Advisors's ABBV Position: Q1 2026 in Review

AssuredPartners Investment Advisors increased its AbbVie (ABBV) stake by 218% in Q1 2026, buying an estimated $3.72M and bringing the position to 24,452 shares worth $5.05M. The position accounts for 0.55% of the portfolio, ranked #45.

AssuredPartners Investment Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • AssuredPartners Investment Advisors held 24,452 shares of AbbVie worth $5.05M as of Q1 2026.
  • AssuredPartners Investment Advisors bought 16,772 AbbVie shares in Q1 2026, an estimated $3.72M.
  • AbbVie made up 0.55% of AssuredPartners Investment Advisors's portfolio in Q1 2026, its #45 holding.
  • AssuredPartners Investment Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AssuredPartners Investment Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.